CB1 Capital Management

CB1 Capital Management is a specialized investment advisory firm focused on the cannabinoid-based wellness and bio-pharmaceutical sectors. The firm identifies and invests in companies utilizing the cannabis plant and its derivatives for medical and therapeutic applications, particularly those targeting the endocannabinoid system. CB1 Capital provides strategic capital and guidance to businesses across the life sciences spectrum, including drug discovery, clinical research, and specialized healthcare services. Their portfolio emphasizes science-driven companies working toward regulatory approval for cannabinoid-based treatments for various medical conditions. The firm is recognized for its expertise in the 'Cannabinoid-Based Medicine' (CBM) space and its focus on the medicalization of the cannabis industry.